Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bradykinin Receptor Antagonism During Cardiopulmonary Bypass
NCT00223704Phase 3Completed
- Sponsor
- Vanderbilt University
- Start
- May 2006
- Primary completion
- Jun 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of icatibant, sponsored by Vanderbilt University. Started May 2006; status: completed.
02
Drugs
icatibant
Beyond the preview
Go deeper on NCT00223704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00223704.